R9	Appositive Attribute:T77 Head:T17
R10	PredicateNominative Attribute:T59 Head:T35
R11	PredicateNominative Attribute:T59 Head:T5
R12	Anaphora Anaphor:T58 Antecedent:T35
R13	Anaphora Anaphor:T75 Antecedent:T15
R14	Anaphora Anaphor:T87 Antecedent:T48
R15	Anaphora Anaphor:T87 Antecedent:T22
R16	Anaphora Anaphor:T88 Antecedent:T27
R17	Anaphora Anaphor:T88 Antecedent:T26
R18	Anaphora Anaphor:T88 Antecedent:T28
R19	Anaphora Anaphor:T88 Antecedent:T29
T2	Drug 1333 1343	cilostazol
T3	Drug 1348 1359	clopidogrel
T6	Drug 1558 1564	PLETAL
T7	Drug_Class 1588 1608	inhibitors of CYP3A4
T8	Drug 1617 1629	ketoconazole
T9	Drug 1634 1646	erythromycin
T10	Drug_Class 1650 1671	inhibitors of CYP2C19
T11	Drug 1680 1690	omeprazole
T12	Drug 1739 1749	omeprazole
T13	Drug 1754 1766	erythromycin
T15	Drug 1816 1826	cilostazol
T16	Drug_Class 1990 2009	inhibitor of CYP3A4
T17	Drug 1976 1985	diltiazem
T19	Drug 1924 1934	cilostazol
T21	Drug 2605 2611	PLETAL
T22	Drug_Class 2626 2644	antiplatelet agent
T23	Drug_Class 2914 2934	inhibitors of CYP3A4
T24	Drug_Class 3030 3051	inhibitors of CYP2C19
T25	Drug_Class 2307 2326	antiplatelet agents
T26	Drug 2983 2992	diltiazem
T27	Drug 2938 2950	ketoconazole
T28	Drug 2952 2964	itraconazole
T29	Drug 2966 2978	erythromycin
T30	Drug 2219 2229	lovastatin
T31	Drug 969 980	Clopidogrel
T32	Drug 1090 1101	clopidogrel
T33	Drug 3055 3065	omeprazole
T34	Drug 8 18	cilostazol
T35	Drug 48 58	Cilostazol
T36	Drug 835 845	cilostazol
T37	Drug 947 957	cilostazol
T38	Drug 1075 1085	cilostazol
T39	Drug 0 6	PLETAL
T40	Drug 283 289	PLETAL
T41	Drug 369 375	PLETAL
T42	Drug 522 528	PLETAL
T43	Drug 584 590	PLETAL
T44	Drug 1459 1465	PLETAL
T45	Drug 2099 2105	PLETAL
T46	Drug 2328 2334	PLETAL
T47	Drug 2551 2557	PLETAL
T48	Drug 2738 2744	PLETAL
T49	Drug 3312 3318	PLETAL
T5	Substance 63 89	several of its metabolites
T95	SPAN 636 662	suspected hypersensitivity
T96	SPAN 2188 2194	CYP3A4
T57	ZeroArticleNP 20 26	tablet
T58	PossessivePronoun 63 89	several of its metabolites
T59	ZeroArticleNP 94 104	inhibitors
T60	DemonstrativeNP 150 175	this pharmacologic effect
T61	ZeroArticleNP 131 144	Several drugs
T62	ZeroArticleNP 244 256	class III-IV
T63	IndefiniteNP 354 366	any severity
T64	IndefiniteNP 562 581	a reversible manner
T65	PossessivePronoun 673 687	its components
T66	DefiniteNP 880 899	The agranulocytosis
T67	DefiniteNP 1027 1039	the efficacy
T68	DefiniteNP 1053 1071	the concurrent use
T69	IndefiniteNP 1103 1141	a platelet-aggregation inhibiting drug
T70	PersonalPronoun 1215 1217	it
T71	IndefiniteNP 1257 1275	an additive effect
T72	ZeroArticleNP 1496 1523	cytochrome P-450 isoenzymes
T73	ZeroArticleNP 1588 1608	inhibitors of CYP3A4
T74	ZeroArticleNP 1650 1671	inhibitors of CYP2C19
T75	PossessivePronoun 1834 1855	its major metabolites
T76	DefiniteNP 1791 1812	the systemic exposure
T77	IndefiniteNP 1987 2009	an inhibitor of CYP3A4
T78	PersonalPronoun 2199 2201	it
T79	IndefiniteNP 2231 2237	a drug
T80	ZeroArticleNP 2167 2172	drugs
T81	IndefiniteNP 2301 2326	other antiplatelet agents
T82	IndefiniteNP 2372 2391	a reversible manner
T83	IndefiniteNP 2616 2644	any other antiplatelet agent
T84	DefiniteNP 2712 2734	The recommended dosage
T85	IndefiniteNP 2782 2789	an hour
T86	IndefiniteNP 2838 2844	A dose
T87	DemonstrativeNP 2909 2934	such inhibitors of CYP3A4
T88	DemonstrativeNP 3025 3051	such inhibitors of CYP2C19
T89	DefiniteNP 3120 3134	the initiation
T90	IndefiniteNP 3201 3220	a beneficial effect
T91	ZeroArticleNP 3138 3145	therapy
T92	ZeroArticleNP 3257 3264	Therapy
T93	DefiniteNP 3266 3284	The available data
T94	DefiniteNP 3298 3308	the dosage
